A Safety Study of ARRY-403 in Patients With Type 2 Diabetes

NCT00952198 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: ARRY-403, glucokinase activator; oral
DRUG: Placebo; oral

Sponsor

Array Biopharma, now a wholly owned subsidiary of Pfizer